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Antinuclear antibodies: cause of disease or caused by disease?
Antinuclear antibodies (ANA) are (auto)antibodies that for ANA is the so-called snRNP (small nuclear ribonucleoprotein) particle. These particles, built from a capped are reactive with antigens in the nucleoplasm. These small nuclear RNA molecule ( U-RNA) and a number antibodies probably occur in the circulation of all human of polypeptides, have an important role in messenger beings, but the employed test is only considered 'positive' RNA processing. Mammalian cells contain more than if they occur at titres elevated significantly above the 14 different U-RNAs and more than 25 different polynormal serum level. ANA were first demonstrated in peptides have been identified as constituents of the 1957 by Holborow et al., using indirect immunofluoresmajor snRNP particles. Of these proteins, the Sm procence [1] . After more than 40 yr, this method is still teins (BB∞, D1/D2/D3, E, F and G) form important used as a screening technique, although the employed antigens for ANA. Other relevant snRNP antigens are substrate has evolved from organ tissue to cultured cells. the 70 kDa, A and C proteins. Since the molecular characterization of (most) antigens, Nuclear antigens also include specificities such as other techniques, such as enzyme-linked immunosorbent RA-33, Ku, PCNA, and nuclear enzymes. For a more assay ( ELISA) and immunoblotting, have been precise description of these, see [2] . Of the more cytodeveloped that allow the precise identification of many plasmic antigens, the La/SS-B protein functions as a ANA specificities. The more precise characterization of termination factor for RNA polymerase III [3] . the involved antigens has also taught us that some ANA Transcripts of RNA polymerase III (such as Y-RNAs, actually react with antigens that do not predominantly 7S RNA, 5S RNA, tRNA, certain viral RNAs) to which occur in the nucleus, but more in the cytoplasm or on La/SS-B is bound form the so-called small cytoplasmic the membrane of the cell. Yet, the term 'antinuclear RNP (scRNP) particles. Ro/SS-A also binds to antibodies' continues to be used for these antibodies.
Y-RNAs, so Ro/SS-A and La/SS-B are often present Elevated levels of ANA are found in all systemic on the same scRNP particle. In human cells, two differrheumatic diseases, with sometimes high, sometimes ent Ro/SS-A molecules have been identified, designated rather loose associations between a particular ANA Ro52 and Ro60. About 30% of both Ro/SS-A and specificity and a particular rheumatic disease. Therefore, La/SS-B is localized in the nucleus of the cell, which the detection and identification of ANA has gained explains the nuclear immunofluorescence of antiincreasing acceptance by clinicians who use the informaRo/SS-A and anti-La/SS-B. tion to help or confirm a diagnosis and in treatment Other cytoplasmic antigens of relevance for ANA follow-up. In this Editorial, we will focus on the role of binding are rRNP (ribosomal RNP) and cytoplasmic ANA in the pathogenesis of rheumatic disease, centred enzymes such as aminoacyl tRNA synthetases (see [2] ). around the question 'Are ANA caused by the disease or At the time patients are diagnosed as having a rheumthe cause of the disease'. First, however, we need to atic disease, ANA are generally already present. For have a closer look at the antigens involved.
certain ANA (e.g. anti-DNA and anti-Scl-70) it has Most ANA are directed against nucleic acids or even been shown that their presence in the circulation proteins associated with nucleic acids. In systemic lupus may precede overt clinical disease by more than 1 yr [4, erythematosus (SLE ), the most predominant antigen is 5]. So it seems a legitimate question to ask is whether probably the nucleosome.
such antibodies indeed mediate the disease features. Nucleosomes form the basic structure of chromatin Traditionally, ANA were considered to play an active and have an important function in the compaction of role in disease, since SLE was considered to be an DNA in the nucleus of the cell. A nucleosome consists immune complex disease. In this concept, ANA bind to of dimers of the four core histones, H2A, H2B, H3 and their respective antigens, either in the circulation or in H4, which together form a histone octamer around situ, and the resulting immune complexes deposit in the which 146 bp of DNA are wrapped twice. Two nucleotissues, where subsequent complement activation leads some subunits are connected via a stretch of linker DNA to inflammation and disease features. Especially in the to which histone H1 is bound. ANA reactive with DNA, case of anti-DNA, deposition of DNA/anti-DNA comespecially if measured by a sensitive and specific radioplexes was supposed to be implicated in the induction immunoassay, are considered the hallmark of SLE.
of lupus nephritis. In later years, this concept was Antibodies to histones (and associated ubiquitons) also modified, based on studies that have shown anti-DNA occur, and more recently, the existence in SLE of to interact with tissue structures such as heparan nucleosome-specific antibodies (i.e. recognizing a consulphate, the major glycosaminoglycan side chain of the formational epitope formed by DNA and histones) has glomerular basement membrane [6, 7] . More recently, been proven. such interactions have been shown to be mediated by nucleosomal material [8]. Another nuclear particle of importance as an antigen
The concept of anti-DNA playing a direct role in the of the cardiology department of a children's hospital, all mothers were found to have anti-Ro/SS-A (and most pathogenesis of SLE is based on much circumstantial evidence. The various pieces of evidence pointing in the of the time also anti-La/SS-B) in their circulation [17] .
Regarding the mechanism of induction of CHB, it has direction of an active role in pathogenesis are:
been suggested that anti-Ro/SS-A and/or anti-La/SS-B (1) Anti-DNA fluctuates in time, in close association react with their corresponding (auto)antigens expressed with exacerbations and remissions of the disease:
on the surface of cells of the fetal cardiac conduction especially nephritic exacerbations are heralded by system [18] . Indeed, anti-Ro/SS-A has been eluted from an increase in the level of anti-DNA, while antiaffected fetal heart tissue [19] . Other proposed mechan-DNA levels drop steeply during the clinical exacerisms include cross-reactivity (of anti-La/SS-B) with fetal bation [9] . In fact, upcoming exacerbations can be laminin, or the existence of a special fetal form of prevented by treatment of patients on the basis of Ro/SS-A (alternative splicing). increasing levels of anti-DNA [10] .
These studies indicate that anti-Ro/SS-A and maybe (2) Patients that do not have SLE at the time antianti-La/SS-B are indeed involved in the pathogenesis of DNA is first detected in their circulation generally
CHB. Yet, in adults, the antibodies seem to be caused develop SLE within the next 5 yr [4] .
by 'disease' only: they are also found in apparently (3) Antibodies to DNA can be eluted from affected healthy women (mothers of CHB children) and in kidneys [11, 12] .
rheumatic patients do not correlate with disease features. (4) Perfusion of rat kidneys with histones, DNA and A correlation between SLE disease exacerbations and antibodies to DNA leads to the binding of antilevels of anti-U1-RNA in the circulation has been dem-DNA to the glomerular basement membrane [13] .
onstrated by Hoet et al. [20] ; yet, whether this implies Initially thought to be based on anti-DNA crossa direct role of this antibody specificity in the pathogenreactivity, we now know this binding is mediated esis of SLE remains to be elucidated. by nucleosomes.
Of the other ANA specificities, some were found to correlate weakly with disease features (or severity), but Taken together, these pieces of evidence indicate that anti-DNA is directly implicated in the induction and no overt roles in the pathogenesis of rheumatic diseases were shown. The absence of disease correlations was propagation of inflammatory reactions in affected tissues.
recently extended to anticardiolipin (including antibeta2-glycoprotein I and antiprothrombin) antibodies In longitudinal studies in patients with SLE or Sjö gren's syndrome, no relationship between serum in patients with SLE or the antiphospholipid syndrome [21] . levels of anti-Ro/SS-A and anti-La/SS-B antibodies and clinical symptoms and/or disease exacerbations could As discussed above, certain ANA specificities seem to be directly involved in the pathogenesis of disease (e.g. be demonstrated [14, 15] . In contrast, in the same patients (SLE group only) anti-DNA activity correlated anti-DNA, anti-Ro/SS-A and maybe anti-U1-RNA), yet most ANA seem not. This would suggest these ANA very well with disease activity. These findings also implicate that anti-Ro/SS-A and anti-La/SS-B responses are to be caused by disease rather than to be the cause of disease. Actually, even though some ANA play a direct regulated independently from anti-DNA. Anti-Ro/SS-A and anti-La/SS-B responses generally correlate with one role in disease features, this still does not explain their existence. This brings us to the question 'What causes another, implicating a central role for scRNP particles in eliciting and sustaining the anti-Ro/SS-A and anti-ANA production'. It is the current view that autoantigens themselves La/SS-B responses [14] . Yet, the absence of a correlation with disease activity defies a crucial role in the pathogendrive the autoimmune response against them. In this view, nucleosomes are probably the most relevant esis of the disease.
An exception to this may be found in the relationship autoantigens for the genesis of antibodies to nucleosomes, histones and DNA. T cells with nucleosome between the presence of anti-Ro/SS-A (and antiLa/SS-B) and the occurrence of isolated congenital heart specificity have been identified in human and murine lupus [22] ; these T cells may not only be involved in the block (CHB) in their offspring. ANA pass the placenta and remain in the circulation of the child for several induction of antinucleosome antibodies, but also of anti-DNA antibodies. Burlingame et al.
[23] have shown weeks after birth. The presence of ANA in the fetal circulation may give rise to neonatal lupus syndrome in that antinucleosome antibodies precede anti-DNA in time in MRL/lpr mice. In SLE, increased levels of the child, and, in some cases the presence of antiRo/SS-A (and anti-La/SS-B) leads to CHB. Antinucleosomes have been identified in the circulation [24] . Our own results (to be published) even show nucleosome Ro/SS-A (present in up to 98% of mothers of CHB patients) was reported to form the largest single risk levels to be inversely related to anti-DNA levels.
With regard to ANA such as anti-Sm, antifactor for the development of CHB in the child [16 ] . Yet, the reported risk of having a child with CHB for U1-RNP/U1-RNA, anti-Ro/SS-A and anti-La/SS-B, the snRNP and scRNP particles might be the antigens anti-Ro/SS-A-positive mothers is only about 5%. This risk increases to about 20% in subsequent pregnancies.
involved. A possible clue to the question how nuclear antigens get exposed to the immune system comes from It is of interest that when (non-rheumatic) mothers of children with isolated CHB were studied in the setting work by Casciola-Rosen et al. [25] , who reported the presence of nucleosomes and other nuclear antigens in exposed to the immune system and become antigenic. These defects alone may indeed lead to autoimmune surface blebs of cells dying from apoptosis. Indeed, apoptosis has in recent years been implicated in autodisease, such as in C1q-deficient patients with SLE, or may predispose for autoimmune disease. In the latter immune disease. Several hypotheses regarding the relationship between apoptosis and autoimmunity have case, environmental factors such as (viral ) infections may then be the trigger that launches the autoimmunity, evolved from these studies:
and, following from that, autoimmune disease, in such (1) A defect in apoptosis may lead to incomplete elimpersons. ination of autoreactive T cells in the thymus. In
Once the autoantibodies are present in a person, some MRL/lpr mice both anti-DNA production and play a direct role in the pathogenesis of the disease (e.g. resulting SLE-like disease are brought about by a anti-DNA in SLE and anti-Ro/SS-A in CHB), but most defect in CD95 (Fas), a receptor implicated in just seem to be the result of the disease and, as such, be apoptosis [26 ] . So far, defects in Fas or its ligand considered epiphenomena of the disease. have not been found to be involved in autoimmune disease in man.
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